Medtronic, Inc. (MDT) Spinal Faces Lawsuits Over Infuse Product  
6/19/2013 8:00:01 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Medtronic Inc. released the results of a third-party independent review of the company’s Infuse Bone Graft product conducted by Yale University. The study, which was started in 2011, follows a year of federal investigation on Medtronic’s payment of authors who wrote studies on Infuse. The investigation turned up no wrongdoing on the company’s part, but a set of 12 recently filed lawsuits against Medtronic in May, filed on behalf of a group of patients who were treated with Infuse, has the company preparing to defend itself again. Infuse was developed and is sold from the company’s Memphis-based spinal division. Company officials couldn’t go into specific details of the lawsuits, but released a statement standing behind Infuse and preparing to “vigorously defend it in court.”

Help employers find you! Check out all the jobs and post your resume.